Immunome, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $9.7M | $57.9M | $49.2M |
| FY2022 | $7.4M | $24.0M | $20.3M |
| FY2023 | $28.7M | $148.5M | $98.7M |
| FY2024 | $59.1M | $240.2M | $143.4M |
| FY2025 | $48.8M | $683.2M | $653.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $9.7M | $57.9M | $49.2M |
| FY2022 | $7.4M | $24.0M | $20.3M |
| FY2023 | $28.7M | $148.5M | $98.7M |
| FY2024 | $59.1M | $240.2M | $143.4M |
| FY2025 | $48.8M | $683.2M | $653.5M |